Background/aims Up-to-date, stratified estimates of the number of individuals affected by glaucoma in the UK are lacking.

Adamas Trust, Inc. is rated a Hold, offers a compelling 10.8% yield on its ADAMM preferred shares. Learn more about ADAM ...